Clear Street’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Clear Street’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.55K	Buy	34,082 +100	+0.3%	+$8	﹤0.01%	1024
2025 Q4	$1.7K	Hold	33,982	–	–	﹤0.01%	859
2025 Q3	$1.76K	Hold	33,982	–	–	﹤0.01%	760
2025 Q2	$1.61K	Buy	33,982 +5,291	+18%	+$267	﹤0.01%	595
2025 Q1	$2.21K	Buy	28,691 +100	+0.3%	+$9	﹤0.01%	460
2024 Q4	$2.63K	Hold	28,591	–	–	﹤0.01%	451
2024 Q3	$1.84K	Sell	28,591 -100	-0.3%	-$8	﹤0.01%	562
2024 Q2	$1.98K	Buy	28,691 +100	+0.3%	+$5	﹤0.01%	602
2024 Q1	$1.9K	Hold	28,591	–	–	﹤0.01%	582
2023 Q4	$858	Hold	28,591	–	–	﹤0.01%	642
2023 Q3	$6.87K	Sell	28,591 -300	-1%	-$50	﹤0.01%	613
2023 Q2	$1.6K	Buy	28,891 +1,200	+4%	+$82	﹤0.01%	1005
2023 Q1	$2.83K	Buy	27,691 +100	+0.4%	+$7	﹤0.01%	791
2022 Q4	$1K	Buy	27,591 +9,841	+55%	+$823	﹤0.01%	923
2022 Q3	$1K	Buy	17,750 +17,650	+17,650%	+$2.99K	﹤0.01%	1034
2022 Q2	$0	Buy	+100	New	+$22	﹤0.01%	1034

Other funds holding ESLAW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clear Street's ESLAW Position: Q1 2026 in Review

Clear Street increased its Estrella Immunopharma Warrant (ESLAW) stake by 0.29% in Q1 2026, buying an estimated $8 and bringing the position to 34,082 shares worth $2.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Clear Street first reported a position in ESLAW in Q2 2022 and has held it in 16 quarters since. The position peaked at $6.87K in Q3 2023. 8 funds tracked by Wall St. Rank hold ESLAW as of Q1 2026.

Clear Street held 34,082 shares of Estrella Immunopharma Warrant worth $2.55K as of Q1 2026.
Clear Street bought 100 Estrella Immunopharma Warrant shares in Q1 2026, an estimated $8.
Estrella Immunopharma Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #1024 holding.
Clear Street first reported a position in Estrella Immunopharma Warrant in Q2 2022 and has held it in 16 quarters since.
Clear Street's Estrella Immunopharma Warrant position peaked at $6.87K in Q3 2023.
8 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.